Basic Information
| LncRNA/CircRNA Name | HSPC324 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | RT-qPCR |
| Sample | LUAD tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | Ectopic expression of lncRNA HSPC324 significantly inhibited proliferation, cell cycle and migration; on the other hand, increased apoptosis and ROS production in lung adenocarcinoma cells. |
| Pubmed ID | 32068121 |
| Year | 2020 |
| Title | LncRNA HSPC324 plays role in lung development and tumorigenesis |
External Links
| Links for HSPC324 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |